This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Università Degli Studi Di Roma "La Sapienza", Universitá Degli Studi Di Siena. Active years: 2018.
Company Filing History:
1 out of 63 
1 out of 18 Years Active: 2018
Title: Alberto Gulino: Innovator in Hedgehog Pathway Inhibitors
Introduction
Alberto Gulino is a prominent inventor based in Rome, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Hedgehog signaling pathway. His work is crucial for advancing treatments for certain types of tumors.
Latest Patents
Alberto Gulino holds a patent for "Multitarget hedgehog pathway inhibitors and uses thereof." This invention focuses on compounds that selectively inhibit the activity of the Hedgehog (Hh) pathway. The compounds are particularly useful in treating Hh-dependent tumors, such as medulloblastoma (MB). He has 1 patent to his name.
Career Highlights
Throughout his career, Alberto has worked with esteemed institutions, including Università Degli Studi Di Siena and Università Degli Studi Di Roma "La Sapienza." His research has contributed to the understanding and treatment of various cancers, showcasing his dedication to improving patient outcomes.
Collaborations
Alberto has collaborated with notable colleagues, including Maurizio Botta and Bruno Botta. Their combined expertise has furthered research in the field of cancer therapeutics.
Conclusion
Alberto Gulino's innovative work in developing Hedgehog pathway inhibitors highlights his commitment to advancing medical science. His contributions are vital for the ongoing fight against cancer, and his research continues to inspire future innovations.